RECURRENT WHO GRADE 3 GLIOMA
Clinical trials for RECURRENT WHO GRADE 3 GLIOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT WHO GRADE 3 GLIOMA trials appear
Sign up with your email to follow new studies for RECURRENT WHO GRADE 3 GLIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
First-in-Human trial tests re-engineered immune cells to fight aggressive brain cancer
Disease control Recruiting nowThis early-stage study is testing a new type of personalized cell therapy for adults with aggressive brain tumors that have returned after prior treatment. Doctors take a patient's own immune cells, modify them in a lab to better target the cancer, and then infuse them back into …
Matched conditions: RECURRENT WHO GRADE 3 GLIOMA
Phase: PHASE1 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated Apr 01, 2026 18:41 UTC
-
Targeted pill tested to control recurrent brain tumors
Disease control Recruiting nowThis study is testing whether a pill called erdafitinib can help control a specific type of recurrent brain tumor (glioma) that has a particular genetic change. It is for adults whose tumors have grown back or worsened after initial treatment. The drug aims to block a faulty prot…
Matched conditions: RECURRENT WHO GRADE 3 GLIOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC